Amanda K. Johnson-Bazira
No Rating Available
(Learn About Our Rating System)

Amanda K. Johnson-Bazira, MD, MPH, CPH

Languages spoken: English, Swahili

Clinical Locations

Primary Location

Primary Children's Hospital

Cancer Blood and Marrow Clinic
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-4700
Get Directions

Dr. Johnson received her medical degree from the University of Minnesota-Twin Cities, completed her Pediatric residency at Duke University, her Pediatric Hematology-Oncology fellowship at Oregon Health and Science University and her Pediatric Blood and Marrow Transplant and Cellular Therapy fellowship at the University of Minnesota-MHealth Fairview Masonic Children’s Hospital. During her time in Oregon, she also completed her Masters of Public Health (MPH) at Oregon Health and Science University-Portland State University School of Public Health.

She is currently an Assistant Professor of Pediatrics at the University of Utah and is in the division of Hematology, Oncology, and Bone Marrow Transplant at Primary Children’s Medical Center. Dr. Johnson’s primary clinical interests include blood and marrow transplantation and cellular therapies for leukemia and lymphoma. She is also interested in global oncology. Her research interests include utilizing mobile health and technology to support patients and caregivers as well as chronic graft-versus-host disease.

Specialties

Board Certification

National Board of Public Health Examiners (Certified in Public Health)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Dr. Johnson received her medical degree from the University of Minnesota-Twin Cities, completed her Pediatric residency at Duke University, her Pediatric Hematology-Oncology fellowship at Oregon Health and Science University and her Pediatric Blood and Marrow Transplant and Cellular Therapy fellowship at the University of Minnesota-MHealth Fairview Masonic Children’s Hospital. During her time in Oregon, she also completed her Masters of Public Health (MPH) at Oregon Health and Science University-Portland State University School of Public Health.

She is currently an Assistant Professor of Pediatrics at the University of Utah and is in the division of Hematology, Oncology, and Bone Marrow Transplant at Primary Children’s Medical Center. Dr. Johnson’s primary clinical interests include blood and marrow transplantation and cellular therapies for leukemia and lymphoma. She is also interested in global oncology. Her research interests include utilizing mobile health and technology to support patients and caregivers as well as chronic graft-versus-host disease.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Hematology/Oncology
Board Certification
National Board of Public Health Examiners (Certified in Public Health)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Biochemistry/Molecular Biology and Mathematics - Cornell College B.A.
Professional Medical Medicine - University of Minnesota Medical School M.D.
Residency Pediatrics - Duke University School of Medicine/Duke University Hospital Intern/Resident
Fellowship Pediatric Hematology/Oncology - Oregon Health & Science University/Doernbecher Children's Hospital Fellow
Graduate Training Health Promotion - Oregon Health & Science University - Portland State University School of Public Health M.P.H.
Fellowship Pediatric Blood and Marrow Transplant and Cellular Therapies - University of Minnesota Medical School Fellow

Selected Publications

Journal Article

  1. Liang S, Salim A, Johnson AK, Yarosh S, Shin JY (2026). "I'll Just Do It": Delegation and the Hidden Costs of Activating Support in Family Caregiving. CHI EA '26: Proceedings of the Extended Abstracts of the CHI Conference on Human Factors in Computing System,
  2. Johnson A, Smeallie E, Roslin C, Rozwadowski M, Shereck E, Choi S (2026). "Tough Things You're Going to Have to Go Through": Dyadic Interview Study Including the Perspectives and Needs of Patients and Their Caregivers Post-Hematopoietic Cell Transplant. Journal of participatory medicine, 18, e81971.
  3. Rayes A, Ramachandran A, Pulsipher MA, Dolan JG, Cho S, Johnson AK, Alexander JL, Borna S, Bacchetta (2026). Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3. Journal of human immunity, 2(3), e20250249.
  4. Salim A, Johnson AK, Yarosh S, Shin J (2025). "Count on Me": Enabling collaboration through active support for primary family caregivers in chronic illness care. CHI EA '25: Proceedings of the Extended Abstracts of the CHI Conference on Human Factors in Computing Systems, (6), 1-8.
  5. Ng B, Harris AC, Abdossamadi S, Lauener MP, Aubert G, Bajwa R, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin L, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Sava'an S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Geltink RIK, Gilman A, Wolff D, Cuvelier GDE, Schultz K (2025). Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort. Transplantation and cellular therapy,
  6. Ng B, Harris AC, Abdossamadi S, Aubert G, Bajwa RP, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin LM, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Sava'an S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Gilman A, Klein Geltink RI, Wolff D, Cuvelier GDE, Schultz K (2025). Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation. Blood,
  7. Cao X, Rozwadowski M, Braun TM, Carlozzi NE, Hassett AL, Johnson AK, Shereck E, Hanauer DA, Choi S (2025). A Mobile Health Intervention in Caregivers of Patients Undergoing Hematopoietic Cell Transplantation: A Randomized Controlled Trial to Examine Health-Related Quality of Life. BMC digital health, 3(1),
  8. Johnson AK, Cornea S, Goldfarb S, Cao Q, Heneghan JA, Gupta A (2024). Risk factors predicting need for the pediatric intensive care unit (PICU) post-hematopoietic cell transplant, PICU utilization, and outcomes following HCT: a single center retrospective analysis. Frontiers in pediatrics, 12, 1385153.
  9. Johnson AK, Goteti S, Devald B, Mestnik S, Ghosh T, Williams R, Doughty ES, Linden MA, Beckman A, Williams T, Richardson K, Martinelli (2024). Pediatric TAFRO syndrome: A multi-institution case series illustrating clinical challenges and excellent outcomes. Pediatric blood & cancer, 71(10), e31234.
  10. Johnson A, Johnson T, Winsnes K, Davis JL (2023). NUT carcinoma: A rare presentation of a chest mass with hypercalcemia in a pediatric patient. Human Pathology Reports, 31.
  11. Edwards ST, Johnson A, Park B, Eiff P, Guzman CEV, Gordon L, Taylor C, Tuepker A (2023). "What We're Doing Now'Is More Than Water Cooler": Perspectives of Primary Care Leaders on Leading Through (and Beyond) COVID-19.(Epub ahead of print). J Gen Intern Med.
  12. Tuepker A, Johnson A, Manriquez L, Park S, Erin R, Zinler KA, Sciammas CL, Lacayo BA, Park B (2023). The impacts of relational organizing for health system and community collaboration: Early evidence from a rapid multisite qualitative study.(Epub ahead of print). Health Serv Res.
  13. Smealie E, Rosenthal L, Johnson A, Roslin C, Hassett AL, Choi SW (2022). Enhancing Resilience in Family Caregivers Using an mHealth App. Appl Clin Inform, 13(5), 1194-1206.
  14. Johnson A (2022). Living in the Dying. J Palliat Med, 25(8), 1313.
  15. Githang'a J, Brown B, Chitsike I, Schroeder K, Chekwenda-Makore N, Majahasi F, Ogundoyin O, Renner L, Petricca K, Denburg AE, Horton SE, Gupta S, et al (2021). The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa. Cancer, 127(5), 787-793.
  16. Johnson A, Yang F, Gollarahalli S, Banerjee T, Abrams D, Jonassaint J, Jonassaint C, Shah N (2019). Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study. JMIR Mhealth Uhealth, 7(12), e13671.

Editorial

  1. Johnson AK, Choi SW (2022). Stakeholder engagement, proper planning and modular design for mHealth apps: lessons from QuestExplore and working toward standards for mHealth app design. Mhealth, 8, 29.

Other

  1. Johnson A (2023). ASPHO Early Career Mentoring Video. American Society of Pediatric Hematology/Oncology.
  2. Johnson A (2020). COVID-19 and Mental Health Providers. COVID-19 and Environmental Health Oregon Health & Science University School of Public Health.

Video/Film/CD/Web/Podcast

  1. Tidwell M, Hill E, and Johnson (2024). Women in White Coats Episode 10: Amanda Johnson.